Back to Journals » HIV/AIDS - Research and Palliative Care » Volume 2

Novel mechanisms of central nervous system damage in HIV infection

Authors Hazleton JE, Berman JW, Eugenin E

Published 11 March 2010 Volume 2010:2 Pages 39—49

DOI https://doi.org/10.2147/HIV.S9186

Review by Single-blind

Peer reviewer comments 3


Joy E Hazleton1, Joan W Berman1,2, Eliseo A Eugenin1

1Department of Pathology and 2Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY, USA

Abstract: Human immunodeficiency virus-1 infection of the central nervous system is an early event after primary infection, resulting in motor and cognitive defects in a significant number of individuals despite successful antiretroviral therapy. The pathology of the infected brain is characterized by enhanced leukocyte infiltration, microglial activation and nodules, aberrant expression of inflammatory factors, neuronal dysregulation and loss, and blood–brain barrier disruption. Months to years following the primary infection, these central nervous system insults result in a spectrum of motor and cognitive dysfunction, ranging from mild impairment to frank dementia. The mechanisms that mediate impairment are still not fully defined. In this review we discuss the cellular and molecular mechanisms that facilitate impairment and new data that implicate intercellular communication systems, gap junctions and tunneling nanotubes, as mediators of human immunodeficiency virus-1 toxicity and infection within the central nervous system. These data suggest potential targets for novel therapeutics.
Keywords: AIDS, dementia, inflammation, gap junctions, nanotubes, chemokines

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]